Tasneem Z. Naqvi, MD1
Articles
Iatrogenic dilated cardiomyopathy and spectrum of current treatment modalities
Tasneem Z. Naqvi, MD1;Jing Zhang MD, PhD2;Leslie Saxon, MD1: From the 1Division of Cardiology, University of Southern California, Keck School of Medicine;the Department of Anesthesia Cardiovasc
September 4th 2008Our increasing ability to intervene in high-risk patients—with lower risks and greater chances for successful outcomes—is felt across the broad spectrum of cardiovascular disease. This is particularly evident in patients with dilated cardiomyopathy (DCM).
Read More
Latest Updated Articles
Published: May 2nd 2024 | Updated: May 6th 2024
Cardiology Month in Review: April 2024
Published: September 23rd 2014 | Updated: October 13th 2024
Itchy, Oozing Rash
Published: October 10th 2024 | Updated: October 13th 2024
Considerations for Clinicians When Prescribing Muscarinic Modulators in Schizophrenia, with Chelsie Monroe
Published: October 9th 2024 | Updated: October 13th 2024
AHN Welcomes New Physicians
Published: October 5th 2024 | Updated: October 13th 2024
FDA News Month in Review: September 2024
Published: April 30th 2024 | Updated: October 13th 2024
Discussing Risankizumab, Differences in IL-23 Inhibitor Epitopes with Christopher Bunick, MD, PhD
